Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

4312 results

Sort By:

Evaluating Tools to Communicate Scleroderma Research Results to Patients - Trial #1

Study ID: NCT06373263
Start Date: 2025-12
End Date: 2025-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

128

Intervention / Treatment

Plain-language summary

Dissemination Tool (Infographic)

Sponsor

Lady Davis Institute

Source: clinicaltrials.gov

Share:
Add to list

Glaucoma Exercise as Medicine Study (GEMS).

Study ID: NCT05581498
Start Date: 2025-12
End Date: 2028-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

150

Intervention / Treatment

Exercise, Bike exercise and muscle strength exercise.

Sponsor

Johns Hopkins University

Source: clinicaltrials.gov

Share:
Add to list

A Study on Peginterferon Alfa-2b Combined With NAs in Compensated HBV Cirrhosis

Study ID: NCT07183293
Start Date: 2025-10
End Date: 2031-09
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment

Peginterferon alfa-2b combined with NAs

NAs

Sponsor

Xiamen Humanity Hospital

Source: clinicaltrials.gov

Share:
Add to list

Clinical Trial Phase I/IIa to Evaluate the Safety and Immunogenicity of StreptInCor

Study ID: NCT07078357
Start Date: 2025-10-01
End Date: 2028-12-01
Study Type

Interventional

Study Phase

Phase2

No. of Participants

60

Intervention / Treatment

StrepIncor

Placebo

Sponsor

University of Sao Paulo General Hospital

Source: clinicaltrials.gov

Share:
Add to list

Painful Post-Operative Hip Study

Study ID: NCT07066709
Start Date: 2025-10
End Date: 2026-08
Study Type

Interventional

Study Phase

Phase2

No. of Participants

15

Intervention / Treatment

FDG PET/MRI

Sponsor

University of Wisconsin, Madison

Source: clinicaltrials.gov

Share:
Add to list

Effectiveness of Bupivacaine, Ketorolac, Ketamine, vs Bupivacaine Alone in Reducing Postoperative Pocket Pain

Study ID: NCT05575999
Start Date: 2026-01
End Date: 2026-12
Study Type

Interventional

Study Phase

Phase1

No. of Participants

200

Intervention / Treatment

Bupivacaine alone OR Bupivacaine-Ketorolac-Ketamine (BKK) Combination

Sponsor

Kansas City Heart Rhythm Research Foundation

Source: clinicaltrials.gov

Share:
Add to list

Systematically Assessing Effects of Colored Light on Humans With a Multi-modal Approach (Substudy 6 of 7)

Study ID: NCT02919163
Start Date: 2025-12-01
End Date: 2027-07-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

50

Intervention / Treatment

Visible light exposure

Sponsor

University of Bern

Source: clinicaltrials.gov

Share:
Add to list

Globus Reflect Tether - HUD

Study ID: NCT06521814
Start Date: 2025-11-01
End Date: 2033-08-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

20

Intervention / Treatment

REFLECT scoliosis correction system

Sponsor

Medical University of South Carolina

Source: clinicaltrials.gov

Share:
Add to list

Yuva Sath: A Peer-led Behavioral Intervention to Support Substance Use Treatment and HIV Prevention Among Young People Who Inject Drugs in India

Study ID: NCT06510192
Start Date: 2026-01
End Date: 2027-12
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

60

Intervention / Treatment

Youth with

Sponsor

Massachusetts General Hospital

Source: clinicaltrials.gov

Share:
Add to list

Southeastern ATTR Amyloidosis Consortium: SEATTRAC Family Registry

Study ID: NCT05974644
Start Date: 2025-11
End Date: 2030-12-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

1000

Intervention / Treatment

Registry

Sponsor

Virginia Commonwealth University

Source: clinicaltrials.gov

Share:
Add to list